Sign inJoin waitlistJoin the waitlist

MF

Michelle Fanale

Medical Oncology

Credentials: ·

History

Medical Oncology
Internal Medicine

Research

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study
Journal of Clinical Oncology · 2012 · 809 citations
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Journal of Clinical Oncology · 2017 · 791 citations
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
The Lancet Oncology · 2016 · 758 citations

YO
Yasuhiro Oki
70 papers
Luis Fayad
61 papers
Sattva Neelapu
49 papers
NF
Nathan Fowler
47 papers
JR
Jorge Romaguera
42 papers
AY
Anas Younes
41 papers
Fredrick Hagemeister
40 papers
FS
Felipe Samaniego
37 papers
Loretta Nastoupil
35 papers · 12 as a fellow
Chelsea Pinnix
34 papers
Jason Westin
34 papers
Bouthaina Dabaja
33 papers